Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial.
Bredewold OW, Chan J, Svensson M, Bruchfeld A, de Fijter JW, Furuland H, Grinyo JM, Hartmann A, Holdaas H, Hellberg O, Jardine A, Mjörnstedt L, Skov K, Smerud KT, Soveri I, Sørensen SS, Zonneveld AV, Fellström B. Bredewold OW, et al. Among authors: grinyo jm. Kidney Med. 2022 Nov 18;5(1):100574. doi: 10.1016/j.xkme.2022.100574. eCollection 2023 Jan. Kidney Med. 2022. PMID: 36593877 Free PMC article.
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial.
Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L; Envarsus study group. Budde K, et al. Among authors: grinyo jm. Am J Transplant. 2014 Dec;14(12):2796-806. doi: 10.1111/ajt.12955. Epub 2014 Oct 2. Am J Transplant. 2014. PMID: 25278376 Free article. Clinical Trial.
Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet.
Vincenti F, Budde K, Grinyo J, Rostaing L, Kirk AD, Larsen CP. Vincenti F, et al. Am J Transplant. 2023 Oct;23(10):1483-1484. doi: 10.1016/j.ajt.2023.05.033. Epub 2023 Jun 9. Am J Transplant. 2023. PMID: 37394381 Free article. No abstract available.
Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approach.
Fernández-Alarcón B, Nolberger O, Vidal-Alabró A, Rigo-Bonnin R, Grinyó JM, Melilli E, Montero N, Manonelles A, Coloma A, Favà A, Codina S, Cruzado JM, Colom H, Lloberas N. Fernández-Alarcón B, et al. Among authors: grinyo jm. Front Pharmacol. 2024 Sep 19;15:1456565. doi: 10.3389/fphar.2024.1456565. eCollection 2024. Front Pharmacol. 2024. PMID: 39364055 Free PMC article.
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.
Vidal-Alabró A, Colom H, Fontova P, Cerezo G, Melilli E, Montero N, Coloma A, Manonelles A, Favà A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Vidal-Alabró A, et al. Among authors: grinyo jm. Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):204-216. doi: 10.1016/j.nefroe.2024.03.019. Epub 2024 Apr 12. Nefrologia (Engl Ed). 2024. PMID: 38614890 Free article.
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N, Grinyó JM, Colom H, Vidal-Alabró A, Fontova P, Rigo-Bonnin R, Padró A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Favà A, Torras J, Cruzado JM. Lloberas N, et al. Among authors: grinyo jm. Kidney Int. 2023 Oct;104(4):840-850. doi: 10.1016/j.kint.2023.06.021. Epub 2023 Jun 28. Kidney Int. 2023. PMID: 37391040 Free article. Clinical Trial.
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations.
Fontova P, van Merendonk LN, Vidal-Alabró A, Rigo-Bonnin R, Cerezo G, van Oevelen S, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Torras J, Cruzado JM, Grinyó JM, Colom H, Lloberas N. Fontova P, et al. Among authors: grinyo jm. Pharmaceutics. 2023 May 12;15(5):1481. doi: 10.3390/pharmaceutics15051481. Pharmaceutics. 2023. PMID: 37242723 Free PMC article.
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach.
Lalagkas PN, Iliou J, Rigo R, Miarons M, Fernández-Alarcon B, Bestard O, Cruzado JM, Melilli E, Torras J, Grinyó JM, Lloberas N, Colom H. Lalagkas PN, et al. Among authors: grinyo jm. Clin Pharmacokinet. 2023 Jun;62(6):861-880. doi: 10.1007/s40262-023-01237-3. Epub 2023 May 4. Clin Pharmacokinet. 2023. PMID: 37140726 Free PMC article.
325 results